Workflow
VTR(300381)
icon
Search documents
溢多利(300381) - 300381溢多利投资者关系管理信息20251224
2025-12-24 12:08
Group 1: Company Overview and Financial Performance - The company, Guangdong Yiduoli Biotechnology Co., Ltd., has registered products in over 30 countries and regions globally, with subsidiaries in Germany, Australia, and a representative office in Russia, and is in the process of establishing a subsidiary in Brazil, expected to be completed in the first half of next year [1][2]. - The company's gross profit margin has consistently remained above 40%, while the net profit margin is only around 3%, primarily due to increased R&D and financial expenses [4]. - Capital expenditures have increased due to the upgrade of the R&D center and the establishment of new production bases, with significant projects currently under construction [4]. Group 2: Market Strategy and Challenges - The company is developing targeted strategies to mitigate potential negative impacts from U.S.-China trade tensions, including collaborating with traders and establishing local brands [2]. - The sales proportion in the U.S. market is currently small, indicating that related policies are unlikely to significantly affect the company's operations [2]. Group 3: Product Development and Sales - The company currently engages in NMN business as a raw material OEM for clients [3]. - The newly launched hydrogen peroxide enzyme product is used in the cleaning process of electronic products, with sales and gross margins improving compared to the previous year, although its overall revenue contribution remains small [5].
溢多利:截至2025年12月10日公司股东人数为20324户
Zheng Quan Ri Bao Wang· 2025-12-17 13:12
Group 1 - The core point of the article is that Yiduoli (300381) has reported its shareholder count as of December 10, 2025, which stands at 20,324 households [1]
溢多利(300381.SZ):公司目前没有工业大麻业务
Ge Long Hui· 2025-12-17 06:53
Group 1 - The core viewpoint of the article is that Yiduoli (300381.SZ) currently does not have any industrial hemp business [1] Group 2 - The company communicated this information through its investor interaction platform [1]
溢多利:公司食品用酶包括耐高温α-淀粉酶等系列产品
Zheng Quan Ri Bao· 2025-12-08 14:14
Core Viewpoint - Yidoli is actively enhancing its product offerings in the food enzyme sector through continuous research and development, aiming to improve strain performance and production processes while expanding its competitive edge in the food industry [2] Group 1: Product Offerings - The company’s food enzymes include high-temperature α-amylase, fungal α-amylase, pullulanase, xylanase, and glucose oxidase, which are widely used in industries such as starch sugar, alcohol, beverages, and baking [2] Group 2: Innovation and Market Demand - The company plans to strengthen application research and development in the food industry to launch new products that meet market demands, thereby further enhancing its product competitiveness [2]
溢多利:截至2025年11月28日公司股东人数为20286户
Zheng Quan Ri Bao· 2025-12-03 11:13
证券日报网讯 12月3日,溢多利在互动平台回答投资者提问时表示,截至2025年11月28日,公司股东人 数为20286户。 (文章来源:证券日报) ...
溢多利:关于控股股东部分股份质押及解除质押的公告
Zheng Quan Ri Bao· 2025-12-01 13:13
Group 1 - The core point of the article is that Yiduoli announced the pledge and release of shares by its controlling shareholder, Zhuhai Jindadi Investment Co., Ltd. [2] - The pledged shares amount to 12.5 million shares, with the pledge starting on November 27, 2025, and the release date set for November 28, 2025 [2]
溢多利:金大地投资累计质押股数为3750万股
Mei Ri Jing Ji Xin Wen· 2025-12-01 08:44
Group 1 - The core point of the article is that Yiduoli (SZ 300381) announced that as of the announcement date, Jindadi Investment has pledged a total of 37.5 million shares, accounting for 26.32% of its holdings [1] - For the year 2024, Yiduoli's revenue composition is as follows: 83.57% from the biomanufacturing industry, 15.71% from the bio-agriculture and animal husbandry industry, and 0.72% from other industries [1] - The current market capitalization of Yiduoli is 3.4 billion yuan [2]
溢多利:控股股东1250万股股份质押及解除质押
Xin Lang Cai Jing· 2025-12-01 08:17
Core Viewpoint - The announcement from Yiduoli indicates that the controlling shareholder, Jindadi Investment, has pledged 12.5 million shares, which represents 8.77% of its holdings and 2.55% of the company's total share capital, for debt repayment purposes [1] Group 1 - On November 27, Jindadi Investment notified the company about the pledge of 12.5 million shares, with a maturity date set for November 26, 2027 [1] - The pledged shares were released on November 28, with the same percentage representation as the pledge [1] - As of the announcement date, Jindadi Investment has cumulatively pledged 37.5 million shares, accounting for 26.32% of its holdings and 7.64% of the company's total share capital, with no risk of forced liquidation or transfer of ownership [1]
溢多利(300381) - 关于控股股东部分股份质押及解除质押的公告
2025-12-01 08:15
股票代码:300381 股票简称:溢多利 公告编号:2025-052 广东溢多利生物科技股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 广东溢多利生物科技股份有限公司(以下简称"公司")于 2025 年 12 月 1 日接到控股股东珠海市金大地投资有限公司(以下简称"金大地投资")的 通知,金大地投资将其所持有的本公司部分股份办理了质押及解除质押手续, 具体事项如下: 一、股东股份质押、解除质押的基本情况 | 股东 | 是否为 第一大 股东及 | 本次质押 数量 | 占其所 持股份 | 占公司总 股本比例 | 是否为 | 是否为补 | 质押 | 质押 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 一致行 | (万股) | 比例 | (%) | 限售股 | 充质押 | 起始日 | 到期日 | | 用途 | | | | | (%) | | | | | | | | | | 动人 | ...
研判2025!中国添加剂预混合饲料行业政策、产业链、产量、竞争格局及未来前景展望:添加剂预混合饲料发展态势良好,2025年1-10月产量同比增长4.01%[图]
Chan Ye Xin Xi Wang· 2025-11-26 02:17
Core Insights - The modern livestock industry is increasingly demanding diverse animal nutrition, leading to higher requirements for feed performance, which traditional standardized products can no longer meet [1] - Additive premix feed fills the market gap with flexible formulation design and precise nutritional supply, improving feed utilization, reducing farming costs, and enhancing animal growth performance and product quality [1] Industry Overview - Additive premix feed consists of two or more nutritional feed additives mixed with carriers or diluents, including compound premix feed, trace element premix feed, and vitamin premix feed [3] - The production of additive premix feed in China has experienced fluctuations, with production reaching 542.6 million tons in 2019, a decrease of 16.9% year-on-year, and recovering to 594.5 million tons in 2020, a growth of 9.6% [1][8] - In 2021, production increased to 663.1 million tons, a year-on-year growth of 11.54%, but fell to 652.2 million tons in 2022 due to various factors, including the pandemic [1][8] - In 2023, production rebounded to 709.1 million tons, an increase of 8.7% year-on-year, but is expected to decline to 695.1 million tons in 2024 due to adjustments in pig production capacity and reduced livestock inventory [1][8] Industry Policies - The industry has seen a series of supportive and regulatory policies aimed at promoting standardization and efficiency, such as the 2024 "Green Sword Protect Grain Safety" enforcement action focusing on illegal production and sales of feed additives [4][6] - The 2025 Feed Quality Safety Supervision Work Plan emphasizes the inspection of banned substances and illegal additives in various feed products, including premix feeds [4][6] Industry Chain - The upstream of the additive premix feed industry includes feed raw materials like soybeans, corn, and fish meal, while the midstream involves the production of various types of premix feeds [6] - The downstream application includes livestock farming sectors such as pig, poultry, and aquaculture [6] Market Dynamics - The additive premix feed market is characterized by a clear competitive structure, with leading companies like New Hope, Tongwei, and Da Bei Nong forming the first tier, while other companies like Haida Group and Zhengbang Technology represent the second tier [10][12] - The market is expected to consolidate further, with smaller companies facing challenges due to limited innovation and sales channels [10][12] Future Trends - The industry is moving towards precise product functionality and value enhancement, focusing on tailored formulations for different livestock species and growth stages [16] - Technological advancements will drive the integration of biotechnology and smart manufacturing, optimizing formulation structures and improving production processes [17] - A comprehensive service model will emerge, extending beyond product provision to include technical support and real-time monitoring for farmers [18]